...available for licensing or partnering from Integral Molecular Inc.; platform available for partnering PUBLICATION DETAILS: Tucker...

...was CMO at Acorda Therapeutics Inc. (NASDAQ:ACOR). Oncology company Deciphera Pharmaceuticals LLC (Lawrence, Kan.) named Tucker...

...Fund , Granite Bay, Calif. Genzyme Corp. , Cambridge, Mass. National Gaucher Foundation Inc. , Tucker...

...retinal disorders. SciBX 6(40); doi:10.1038/scibx.2013.1141 Published online Oct. 17, 2013 Patent and licensing status unavailable Tucker...

...high single-digit royalties. BioLineRx in-licensed the compound from Genoscience (Marseille, France) and RFS Pharma LLC (Tucker...

...be reached for details, in-licensed the compound from Genoscience (Marseille, France) and RFS Pharma LLC (Tucker...

...to potentially resurrect the older amantadine class of drug is a worthy goal," said Simon Tucker...

...Incline Therapeutics Inc. , Redwood City, Calif. Business: Neurology Hired: John Tucker as SVP and chief...

...surprising and might, for example, lead to potentially resurrecting penicillin compounds for MRSA," said Simon Tucker...
...infections, said Tucker. Those new inhibitors are of a different chemical class than PC190723, although Tucker...

...supplement portfolio. Lazard and Houlihan Lokey were financial advisors, while DLA Piper and Rutan & Tucker...